​2025 Tetrahedral Framework Nucleic Acid Industry Development Forum – Media Report

The 2nd Tetrahedral Framework Nucleic Acid Industry Development Forum Successfully Concluded!

At the forum, experts conducted in-depth discussions on the fundamental research, application development, and industrial prospects of tetrahedral framework nucleic acid (tFNA) technology. They shared the latest research findings and practical experience, and explored the challenges and solutions related to technology translation. The event strengthened collaboration between domestic and international research institutions and enterprises, and provided fresh perspectives and momentum for future innovation and industrialization. It further solidified the foundation for the translation and commercialization of tFNA technology in areas such as medicine, ophthalmology, neurological diseases, and skin health.

The forum also attracted more than 300 distinguished participants from various sectors, including government officials, clinical physicians, researchers from academic institutions, senior executives from pharmaceutical companies, and financial industry experts. Their presence brought valuable professional insights and practical experiences to the event, offering crucial suggestions for the cross-sectoral collaboration and multi-field application of tFNA technology.

Guests and attendees gave unanimous praise for the forum’s organization and content, viewing it as a vital platform for the future development of tFNA technology and a catalyst for deep interdisciplinary exchange and cooperation.

Additionally, ten media outlets attended the event to cover the forum, conducting exclusive interviews with Professor Yunfeng Lin, Professor Delun Luo, Professor Xiaoyan Ding, and others. These media included leading outlets such as People’s Daily Online, Sichuan Daily, and Science and Technology Daily. Subsequently, over 30 in-depth articles and interviews were published, offering comprehensive and detailed reports on the forum and the development of the tFNA industry.

These media reports not only highlighted the forum’s major topics and outcomes but also provided insightful analysis on the application prospects and commercialization process of tFNA technology in fields such as biomedicine, ophthalmology, neurological diseases, and skin health.

Thanks to this extensive media coverage, the 2025 2nd Tetrahedral Framework Nucleic Acid Industry Development Forum and its achievements have garnered broader public attention and recognition, further enhancing the influence of the organizing center within both the academic and industrial communities.